Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Safety Study of SEA-BCMA in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT03582033. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Quality of Life Assessment of Caregivers of Patients With Multiple Myeloma
ClinicalTrials.gov study NCT07276230. IPD Sharing: YES. Countries: 1. Publications: 0.
Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma
ClinicalTrials.gov study NCT04999085. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenalidomide and Nivolumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03333746. IPD Sharing: NO. Countries: 1. Publications: 0.
Pethema Multiple Myeloma 2000
ClinicalTrials.gov study NCT00560053. IPD Sharing: Not stated. Countries: 0. Publications: 8.
A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA)
ClinicalTrials.gov study NCT05839626. IPD Sharing: YES. Countries: 7. Publications: 0.
A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis
ClinicalTrials.gov study NCT05775094. IPD Sharing: YES. Countries: 1. Publications: 0.
A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT01672736. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Expanded Access Protocol (EAP) to Provide Bortezomib to Patients With Multiple Myeloma Who Have Received at Least 2 Previous Lines of Therapy and Are Refractory to or Have Relapsed After Their Last Th
ClinicalTrials.gov study NCT00440635. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT04045795. IPD Sharing: YES. Countries: 6. Publications: 0.
Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma
ClinicalTrials.gov study NCT02481934. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease
ClinicalTrials.gov study NCT01949532. IPD Sharing: Not stated. Countries: 3. Publications: 0.
THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)
ClinicalTrials.gov study NCT01341262. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma
ClinicalTrials.gov study NCT00148317. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects
ClinicalTrials.gov study NCT01980589. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bleeding in Multiple Myeloma
ClinicalTrials.gov study NCT06482931. IPD Sharing: NO. Countries: 0. Publications: 7.
UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06698744. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02939183. IPD Sharing: YES. Countries: 4. Publications: 0.
A Study of Belantamab Mafodotin to Investigate Safety, Tolerability, Pharmacokinetics, Immunogenicity and Clinical Activity in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT04177823. IPD Sharing: NO. Countries: 1. Publications: 0.
First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody
ClinicalTrials.gov study NCT03665155. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.